MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617046367 A) filed by Tessera Therapeutics, Inc. on April 10, 2026, for Lipid Nanoparticles For Delivery Of Therapeutic Payloads To Cells.
Inventors include Wang, Zhan; Zhang, Rui; Gu, Han; Wangweerawong, Apiwat; Tozzi, Lorenzo; Palchaudhuri, Rahul; Monte, Michael; Schiroli, Giulia; and Liu, Lei.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The disclosure provides ionizable lipids for constructing lipid nanoparticles. The disclosure further provides conjugates comprising a targeting moiety and a lipid nanoparticle (LNP) encapsulating a therapeutic agent (e.g., payload) for delivery to immune cells, hematopoietic stem cells (HSCs), or liver cells. The conjugates can be delivered to cells ex vivo or formulated in a pharmaceutical composition to be directly administered to a subject in need thereof (e.g., via in vivo administration).
Disclaimer: Curated by HT Syndication.
